title: Clinical manifestations and arsenic methylation after a rare subacute arsenic poisoning accident.
abstract: One hundred and four workers ingested excessive levels of arsenic in an accident caused by leakage of pipeline in a copper-smelting factory. Clinical examinations were performed by physicians in a local hospital. Excreted urinary arsenic species were determined by cold trap hydride generation atomic absorption spectrometry. In the initial toxic phase, gastrointestinal symptoms were predominant (83 people, 79.8%). Most patients showed leucopenia (72 people, 69.2%), and increased serum alanine aminotransferase (84 people, 80.8%) and aspartate aminotransferase (58 people, 55.8%). Thirty-five patients (33.6%) had elevated red blood cells in urine. After 17 days of admission, many subjects (45 people, 43.3%) developed peripheral neuropathy and 25 of these 45 patients (24.0%) showed a decrease in motor and sensory nerve conduction velocity. In the comparison of urinary arsenic metabolites among subacute arsenic-poisoned, chronic high arsenic-exposed and control subjects, we found that subacute arsenic-poisoned patients had significantly elevated proportions of urinary inorganic arsenic (iAs) and methylarsonic acid (MMA) but reduced proportion of urinary dimethylarsinic acid (DMA) compared with chronic high arsenic-exposed and control subjects. Chronic exposed subjects excreted higher proportions of iAs and MMA but lower proportions of DMA in urine compared with control subjects. These results suggest that gastrointestinal symptoms, leucopenia, and hepatic and urinary injury are predominant in the initial phase of subacute arsenic poisoning. Peripheral neuropathy is the most frequent manifestation after the initial phase. The biomethylation of arsenic decreases in a dose rate-dependent manner.
authors.affiliation: Department of Occupational and Environmental Health, College of Public Health, China Medical University, Shenyang, Liaoning, PR China 110001.
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Xu
authors.forename: Yi
authors.initials: Y
authors.lastname: Wang
authors.forename: Quanmei
authors.initials: Q
authors.lastname: Zheng
authors.forename: Bing
authors.initials: B
authors.lastname: Li
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Yaping
authors.initials: Y
authors.lastname: Jin
authors.forename: Xiuqiang
authors.initials: X
authors.lastname: Lv
authors.forename: Guang
authors.initials: G
authors.lastname: Qu
authors.forename: Guifan
authors.initials: G
authors.lastname: Sun
mesh_terms: D000059:Accidents; D000293:Adolescent; D000328:Adult; D000368:Aged; D001151:Arsenic / Q000009:adverse effects* / Q000378:metabolism; D020261:Arsenic Poisoning / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D002681:China; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000473:pathology; D008297:Male; D008745:Methylation; D008875:Middle Aged; D016273:Occupational Exposure; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000473:pathology; D014881:Water Supply
chemical_list: D001151:Arsenic